TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
33 hedge funds and large institutions have $29.8M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$7.74M | |
| 2 | +$5.88M | |
| 3 | +$1.63M | |
| 4 |
Renaissance Technologies
New York
|
+$568K |
| 5 |
AIM
Alambic Investment Management
Belvedere,
California
|
+$213K |
Top Sellers
| 1 | -$3.02M | |
| 2 | -$176K | |
| 3 | -$118K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$66K |
| 5 |
TSS
Two Sigma Securities
New York
|
-$39K |